US5017367A
(en)
*
|
1984-10-01 |
1991-05-21 |
Stojkoski Radmila G |
Skin treatment preparation
|
LU85789A1
(fr)
*
|
1985-02-26 |
1986-09-02 |
Oreal |
Utilisation dans les domaines therapeutique et cosmetique d'une solution anhydre de peroxyde d'hydrogene
|
IT1183530B
(it)
*
|
1985-03-29 |
1987-10-22 |
Monteluos S P A |
Composizioni per cosmesi comprendente perfluoropolieteri
|
US4797272A
(en)
*
|
1985-11-15 |
1989-01-10 |
Eli Lilly And Company |
Water-in-oil microemulsions for cosmetic uses
|
DE3612305A1
(de)
*
|
1986-04-11 |
1987-10-22 |
Roehm Pharma Gmbh |
Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere
|
LU86393A1
(fr)
*
|
1986-04-16 |
1987-12-07 |
Oreal |
Composition anti-acneique stable a base d'erythromycine
|
US4840788A
(en)
*
|
1986-07-15 |
1989-06-20 |
Ici Americas Inc. |
Nonalcoholic sunscreen gel
|
JP2622955B2
(ja)
*
|
1986-07-29 |
1997-06-25 |
エイボン プロダクツ インコ−ポレイテツド |
無水化粧品
|
US4749563A
(en)
*
|
1986-12-08 |
1988-06-07 |
Charles Of The Ritz Group Ltd. |
Moisture-resistant skin treatment compositions
|
US4883654A
(en)
*
|
1987-01-09 |
1989-11-28 |
Young Deborah A |
Cosmetic preparation
|
US5013763A
(en)
*
|
1987-11-30 |
1991-05-07 |
The Andrew Jergens Company |
Wash-off-resistant skin preparation
|
US5141349A
(en)
*
|
1988-05-26 |
1992-08-25 |
Procter & Gamble Company |
Method and apparatus for treating the blade of a razor head
|
US5019376A
(en)
*
|
1989-03-13 |
1991-05-28 |
S. C. Johnson & Son, Inc. |
Sparkling pearlescent personal care compositions
|
US5470567A
(en)
*
|
1989-08-24 |
1995-11-28 |
Bristol Myers Squibb Company |
Synergistic skin depigmentation composition
|
US5002760A
(en)
*
|
1989-10-02 |
1991-03-26 |
Katzev Phillip K |
Retinol skin care composition
|
US5204105A
(en)
*
|
1990-04-10 |
1993-04-20 |
Chanel, Inc. |
Cosmetic composition
|
US5336692A
(en)
*
|
1990-06-28 |
1994-08-09 |
Medicis Pharmaceutical Corporation |
Ointment base and method of use
|
US5273739A
(en)
*
|
1990-12-07 |
1993-12-28 |
Jim Baral |
Composition and treatment for darkening hair color
|
GB9106365D0
(en)
*
|
1991-03-26 |
1991-05-15 |
Bioglan Lab Ltd |
An emollient for use with ultraviolet light
|
US5460808A
(en)
*
|
1991-05-15 |
1995-10-24 |
Chanel, Inc. |
Mascara composition
|
US5254331A
(en)
*
|
1991-09-12 |
1993-10-19 |
Chanel, Inc. |
Skin cream composition
|
FR2681781A1
(fr)
*
|
1991-09-30 |
1993-04-02 |
Oreal |
Composition cosmetique anhydre de maquillage comprenant une phase grasse et procede de traitement cosmetique utilisant cette composition.
|
US5215759A
(en)
*
|
1991-10-01 |
1993-06-01 |
Chanel, Inc. |
Cosmetic composition
|
US5431913A
(en)
*
|
1992-01-24 |
1995-07-11 |
Phillips; Eva J. |
Skin cleansing and exfoliant composition and method of treating skin
|
US5248494A
(en)
*
|
1992-06-10 |
1993-09-28 |
Young Pharmaceuticals Inc. |
Method of reducing anthralin induced inflammation and staining
|
US5391373A
(en)
*
|
1992-07-01 |
1995-02-21 |
Chanel, Inc. |
Skin cream composition
|
US5686086A
(en)
*
|
1992-07-13 |
1997-11-11 |
Shiseido Co., Ltd. |
External skin treatment composition
|
ATE235883T1
(de)
*
|
1992-07-13 |
2003-04-15 |
Shiseido Co Ltd |
Zusammensetzung für dermatologische zubereitung
|
US5962000A
(en)
*
|
1992-07-13 |
1999-10-05 |
Shiseido Company, Ltd. |
External skin treatment composition
|
US5242433A
(en)
*
|
1992-12-07 |
1993-09-07 |
Creative Products Resource Associates, Ltd. |
Packaging system with in-tandem applicator pads for topical drug delivery
|
US5460620A
(en)
*
|
1992-07-31 |
1995-10-24 |
Creative Products Resource, Inc. |
Method of applying in-tandem applicator pads for transdermal delivery of a therapeutic agent
|
WO1994013257A1
(fr)
*
|
1992-12-16 |
1994-06-23 |
Creative Products Resource Associates, Ltd. |
Lotion occlusive ou semi-occlusive pour le traitement de maladies ou de desordres cutanes
|
US5393520A
(en)
*
|
1993-06-11 |
1995-02-28 |
Incando; Peter A. |
Hair treatment method and composition
|
US5413124A
(en)
*
|
1993-08-13 |
1995-05-09 |
Incando; Peter A. |
Hair weft and extension method and article
|
US5352441A
(en)
*
|
1993-09-09 |
1994-10-04 |
Chanel, Inc. |
Powder-based lip liner cosmetic composition
|
US5658580A
(en)
*
|
1993-09-09 |
1997-08-19 |
Chanel, Inc. |
Skin cream composition
|
GB2281697A
(en)
*
|
1993-09-14 |
1995-03-15 |
Euro Celtique Sa |
Laxative compositions in capsules
|
US5866149A
(en)
*
|
1993-12-10 |
1999-02-02 |
L'oreal |
Composition for making up the eyelashes and the eyebrows stabilized oxyethylenated derivatives
|
US5456851A
(en)
*
|
1994-04-07 |
1995-10-10 |
Johnson & Johnson Consumer Products, Inc. |
Ketoconazole shampoo containing butylated hydroxytoluene or butylated hydroxyanisole
|
US5470884A
(en)
*
|
1994-05-19 |
1995-11-28 |
Procter & Gamble |
Anti-acne compositions
|
US5449519C1
(en)
*
|
1994-08-09 |
2001-05-01 |
Revlon Consumer Prod Corp |
Cosmetic compositions having keratolytic and anti-acne activity
|
WO1996006620A2
(fr)
*
|
1994-08-29 |
1996-03-07 |
Wake Forest University |
Analogues de lipides pour le traitement d'infections virales
|
US7135584B2
(en)
*
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
US5646106A
(en)
*
|
1994-12-30 |
1997-07-08 |
Rhone-Poulenc Specialty Chemicals Asia Pacific Pte Ltd |
Cold pearlizing concentrates
|
US5560873A
(en)
*
|
1994-12-30 |
1996-10-01 |
Chen; Pu |
Mild cold pearlizing concentrates
|
US6579516B1
(en)
|
1995-06-13 |
2003-06-17 |
Zahra Mansouri |
Methods of delivering materials into the skin, and compositions used therein
|
US5571503A
(en)
*
|
1995-08-01 |
1996-11-05 |
Mausner; Jack |
Anti-pollution cosmetic composition
|
US5601810A
(en)
*
|
1995-11-22 |
1997-02-11 |
Chanel, Inc. |
Mascara composition
|
US5932553A
(en)
*
|
1996-07-18 |
1999-08-03 |
The Regents Of The University Of California |
Illudin analogs useful as antitumor agents
|
US5723632A
(en)
*
|
1996-08-08 |
1998-03-03 |
Mgi Pharma, Inc. |
Total synthesis of antitumor acylfulvenes
|
US5770206A
(en)
*
|
1996-12-19 |
1998-06-23 |
C&D Master Enterprizes Ltd |
Body oils and method for making the same
|
US6312450B1
(en)
|
1997-05-20 |
2001-11-06 |
Natural Vision Center, Inc. |
System and method for improving the appearance of skin
|
US5962504A
(en)
|
1997-09-08 |
1999-10-05 |
Georgetown University |
Substituted 2-pyrrolidinone activators of PKC
|
US6486214B1
(en)
|
1997-09-10 |
2002-11-26 |
Rutgers, The State University Of New Jersey |
Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
|
CA2282461C
(fr)
*
|
1997-12-29 |
2004-04-20 |
John D. Buynak |
Derives d'acide penicillanique 2.beta.-substitue-6-alkylidene utilises comme inhibiteurs de la beta-lactamase
|
US6432941B1
(en)
|
1998-01-20 |
2002-08-13 |
Parker Hughes Institute |
Vanadium compounds for treating cancer
|
US6051603A
(en)
|
1998-01-20 |
2000-04-18 |
Wayne Hughes Institute |
Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
|
US6245808B1
(en)
|
1998-11-05 |
2001-06-12 |
Parker Hughes Institute |
Oxy-vanadium (IV) complexes having spermicidal activity
|
US7141603B2
(en)
*
|
1999-02-19 |
2006-11-28 |
The Regents Of The University California |
Antitumor agents
|
US6025328A
(en)
|
1998-02-20 |
2000-02-15 |
The Regents Of The University Of California |
Antitumor agents
|
US6355678B1
(en)
*
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
US6800649B1
(en)
*
|
1998-06-30 |
2004-10-05 |
Parker Hughes Institute |
Method for inhibiting c-jun expression using JAK-3 inhibitors
|
US6589537B2
(en)
*
|
1999-02-11 |
2003-07-08 |
Marie Harbeck |
Infant skin care composition
|
US6193987B1
(en)
*
|
1999-02-11 |
2001-02-27 |
Marie Helena Harbeck |
Lubricating composition for hands and skin
|
US6080747A
(en)
*
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
EP1159279B1
(fr)
|
1999-03-09 |
2002-10-16 |
PHARMACIA & UPJOHN COMPANY |
AGENTS ANTIVIRAUX DE 4-OXO-4,7-DIHYDRO-THIENO 2,3-b]PYRIDINE-5-CARBOXAMIDES
|
US6258820B1
(en)
|
1999-03-19 |
2001-07-10 |
Parker Hughes Institute |
Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
US6407091B1
(en)
*
|
1999-04-15 |
2002-06-18 |
Research Corporation Technologies, Inc. |
β-lactamase inhibiting compounds
|
JP4698843B2
(ja)
*
|
1999-05-17 |
2011-06-08 |
エーザイ インコーポレイテッド |
生体活性剤の改良された細胞取り込み
|
US6930101B1
(en)
|
1999-05-17 |
2005-08-16 |
The Regents Of The University Of California |
Thiazolopyrimidines useful as TNFα inhibitors
|
US6551998B1
(en)
*
|
1999-06-22 |
2003-04-22 |
University Of Louisville Research Foundation, Inc. |
Antimicrobial agents
|
US6254594B1
(en)
|
1999-07-30 |
2001-07-03 |
Quadrivium, Llc |
Disposable light source for photothermal treatment of human tissue
|
US7026469B2
(en)
*
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
US6670341B1
(en)
|
1999-10-28 |
2003-12-30 |
Wake Forest University Health Sciences |
Compositions and methods for double-targeting virus infections and targeting cancer cells
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
AU1608801A
(en)
|
1999-11-15 |
2001-05-30 |
Parker Hughes Institute |
Diamino platinum (ii) antitumor complexes
|
US6649654B1
(en)
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
US6589992B2
(en)
|
1999-11-30 |
2003-07-08 |
Parker Hughes Institute |
Inhibiting collagen-induced platelet aggregation
|
US6355280B1
(en)
*
|
2000-02-28 |
2002-03-12 |
I.M.S. Cosmetics |
Composition for reducing cell apoptosis containing avocado and soybean lipid unsaponifiables
|
WO2001070742A1
(fr)
|
2000-03-21 |
2001-09-27 |
Pharmacia & Upjohn Company |
4-hydroxy-1,8-naphtyridine-3-carboxamides en tant qu'agents antiviraux
|
JP2003531195A
(ja)
|
2000-03-21 |
2003-10-21 |
ファルマシア・アンド・アップジョン・カンパニー |
抗ウイルス剤としての4−ヒドロキシシンノリン−3−カルボキサミド
|
NZ521522A
(en)
|
2000-03-21 |
2004-08-27 |
Upjohn Co |
4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides useful as antiviral agents
|
FR2811228B1
(fr)
*
|
2000-07-07 |
2002-10-25 |
Lvmh Rech |
Utilisation d'oligosaccharides ou d'extraits de plantes en contenant comme agent cosmetique ou dermatologique notamment pour stimuler la production de beta-endorphine dans la peau
|
US6682892B2
(en)
*
|
2000-07-13 |
2004-01-27 |
Pharmacia & Upjohn Company |
Method for treating herpes viruses
|
US6696441B1
(en)
|
2000-08-11 |
2004-02-24 |
The Regents Of The University Of California |
Inhibition of p53-induced stress response
|
US6689767B2
(en)
|
2000-09-29 |
2004-02-10 |
Regents Of The University Of Minnesota |
Triterpenes having antibacterial activity
|
EP1322661A1
(fr)
|
2000-09-29 |
2003-07-02 |
Regents Of The University Of Minnesota |
Triterpenes ayant une activite fongicide dirigee contre les levures
|
US6951847B2
(en)
*
|
2000-09-29 |
2005-10-04 |
Regents Of The University Of Minnesota |
Methods of treating fungal infections using lupeol
|
US7309696B2
(en)
|
2000-10-19 |
2007-12-18 |
Wake Forest University |
Compositions and methods for targeting cancer cells
|
US6642221B1
(en)
|
2000-11-15 |
2003-11-04 |
Parker Hughes Institute |
Vanadium compounds as anti-proliferative agents
|
US6958359B1
(en)
*
|
2000-11-15 |
2005-10-25 |
Parker Hughes Institute |
Vanadium compounds as anti-angiogenic agents
|
US6878388B1
(en)
|
2000-11-15 |
2005-04-12 |
Parker Hughes Institute |
Vanadium compounds for treating proliferative cell disorders
|
AU2002249885A1
(en)
|
2000-11-17 |
2002-08-12 |
Adolor Corporation |
Delta agonist analgesics
|
US20040034045A1
(en)
*
|
2000-11-29 |
2004-02-19 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
US7261901B2
(en)
*
|
2001-01-31 |
2007-08-28 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
WO2002060936A2
(fr)
*
|
2001-01-31 |
2002-08-08 |
University Of Iowa Research Foundation |
Vaccin et compositions permettant de prevenir et de traiter des infections induites par neisseria
|
US7232829B2
(en)
*
|
2001-04-06 |
2007-06-19 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
KR20030041130A
(ko)
*
|
2001-05-29 |
2003-05-23 |
코닌클리케 필립스 일렉트로닉스 엔.브이. |
금속-세라믹 접착
|
US7601846B2
(en)
*
|
2001-06-26 |
2009-10-13 |
The Regents Of The University Of California |
Compounds having activity as inhibitors of apoptosis
|
US20030232794A1
(en)
*
|
2001-06-26 |
2003-12-18 |
Cottam Howard B. |
Use of STAT-6 inhibitors as therapeutic agents
|
EP1430060B1
(fr)
*
|
2001-07-24 |
2006-09-13 |
Southern Methodist University Foundation for Research |
7-alkylidene-3-substitues-3-cephem-4-carboxylates utilises en tant qu'inhibiteurs de beta-lactamase
|
US20030171377A1
(en)
*
|
2001-08-29 |
2003-09-11 |
Bigge Christopher Franklin |
Antidiabetic agents
|
MXPA04001917A
(es)
*
|
2001-08-31 |
2004-06-15 |
Thomson Licensing Sa |
Contador de secuencia para una corriente audio-visual.
|
US20040116350A1
(en)
*
|
2001-09-17 |
2004-06-17 |
Paul Wentworth Jr |
Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
|
US20050129680A1
(en)
*
|
2001-09-17 |
2005-06-16 |
Paul Wentworth |
Antimicrobial activity of antibodies
|
US20040157280A1
(en)
*
|
2001-09-17 |
2004-08-12 |
Paul Wentworth |
Antibody mediated ozone generation
|
WO2003029264A2
(fr)
*
|
2001-10-01 |
2003-04-10 |
University Of Virginia Patent Foundation |
Analogues de 2-propynyle adenosine presentant une activite agoniste de a2a et compositions en contenant
|
WO2003031587A2
(fr)
*
|
2001-10-09 |
2003-04-17 |
The Regents Of The University Of California |
Utilisation d'inhibiteurs de stat-6 comme agents therapeutiques
|
SI1465625T1
(sl)
|
2001-11-14 |
2010-06-30 |
Univ Rutgers |
Solubilizirani topoizomerazni strupi
|
EP1478229B1
(fr)
*
|
2001-11-23 |
2009-03-11 |
Rutgers, The State University |
Synthese amelioree de polyanhyrides
|
US7030141B2
(en)
*
|
2001-11-29 |
2006-04-18 |
Christopher Franklin Bigge |
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
|
AU2003205332A1
(en)
*
|
2002-01-25 |
2003-09-02 |
Philip S. Portoghese |
Selective analgesic agents
|
US20080152613A1
(en)
*
|
2002-01-31 |
2008-06-26 |
Norburn Robert B |
Method for manufacturing a skin care composition
|
CA2416305A1
(fr)
*
|
2002-01-31 |
2003-07-31 |
Davies, John |
Rasage, apres-rasage et compositions revitalisantes pour la peau
|
US20080152722A1
(en)
*
|
2002-01-31 |
2008-06-26 |
Norburn Robert B |
Skin care composition
|
WO2003087105A1
(fr)
*
|
2002-04-04 |
2003-10-23 |
Alamx, L.L.C. |
INHIBITEURS DE SERINE ET DE METALLO-ss-LACTAMASES
|
WO2003086408A1
(fr)
*
|
2002-04-10 |
2003-10-23 |
University Of Virginia Patent Foundation |
Utilisation d'agonistes du recepteur d'adenosine a2a dans le traitement de maladies inflammatoires
|
US20040156799A1
(en)
*
|
2002-06-04 |
2004-08-12 |
Zigang Dong |
Cancer treatment method and compositions
|
UA79293C2
(en)
*
|
2002-07-03 |
2007-06-11 |
Univ Wayne State |
4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
|
EP1572093B1
(fr)
*
|
2002-08-01 |
2013-04-17 |
Eisai Inc. |
Prévention du cancer avec la glutamine
|
US6989387B2
(en)
*
|
2002-08-09 |
2006-01-24 |
Rutgers, The State University Of New Jersey |
Nitro and amino substituted topoisomerase agents
|
US7438918B2
(en)
*
|
2002-08-30 |
2008-10-21 |
University Of Iowa Research Foundation |
Lipid A deficient mutants of Neisseria meningitidis
|
AU2003260821A1
(en)
*
|
2002-09-11 |
2004-04-30 |
Warner-Lambert Company Llc |
Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
|
US8900607B1
(en)
|
2002-09-25 |
2014-12-02 |
Chemsil Silicones, Inc. |
Clear, greaseless skin-care compositions
|
EP1565080B1
(fr)
|
2002-10-10 |
2014-01-15 |
Cornell Research Foundation, Inc. |
Nouvelles proteines immunogenes de leptospira
|
WO2004036188A2
(fr)
*
|
2002-10-18 |
2004-04-29 |
Cylene Pharmaceuticals, Inc. |
Procedes servant a identifier des molecules antivirales ciblees vers des structures quadruplex
|
EP2258392A1
(fr)
|
2002-11-08 |
2010-12-08 |
Ablynx N.V. |
Procédé d'administration de polypeptides thérapeutiques
|
EP2267032A3
(fr)
|
2002-11-08 |
2011-11-09 |
Ablynx N.V. |
Procédé d'administration de polypeptides thérapeutiques et polypeptides correspondants
|
BR0315628A
(pt)
*
|
2002-11-14 |
2005-08-23 |
Novartis Ag |
Geração de ozÈnio mediada por anticorpo ou neutrófilo
|
US7297340B2
(en)
*
|
2003-01-07 |
2007-11-20 |
University Of Iowa Research Foundation |
Vaccine and method for preventing biofilm formation
|
US9028816B2
(en)
|
2003-01-10 |
2015-05-12 |
Ablynx N.V. |
Polypeptides and polypeptide constructs comprising single domain antibodies directed against von Willebrand factor
|
US20050079512A1
(en)
*
|
2003-02-26 |
2005-04-14 |
Emerson Beverly M. |
Methods of modulating gene expression
|
US7354916B2
(en)
*
|
2003-04-07 |
2008-04-08 |
Cylene Pharmaceuticals |
Substituted quinobenzoxazine analogs
|
NZ543006A
(en)
*
|
2003-04-07 |
2009-03-31 |
Cylene Pharmaceuticals Inc |
Substituted quinobenzoxazine analogs
|
US7507727B2
(en)
*
|
2003-04-07 |
2009-03-24 |
Cylene Pharmaceuticals, Inc. |
Substituted quinobenzoxazine analogs and methods of using thereof
|
WO2004091627A2
(fr)
*
|
2003-04-07 |
2004-10-28 |
Cylene Pharmaceuticals, Inc. |
Analogues heterocycliques de 1,4-dihydro-4-oxo-1,8-naphthpyridine substitues
|
ATE478663T1
(de)
|
2003-06-25 |
2010-09-15 |
Burnham Inst |
Analoga von apogossypol zur verwendung in der behandlung von krebs
|
WO2005003140A1
(fr)
*
|
2003-07-02 |
2005-01-13 |
Pharmacia & Upjohn Company Llc |
4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides utilises comme agents antiviraux
|
BRPI0413922B8
(pt)
|
2003-08-25 |
2021-05-25 |
Adenosine Therapeutics Llc |
xantinas de 8-heteroarila substituída
|
US9532994B2
(en)
|
2003-08-29 |
2017-01-03 |
The Regents Of The University Of California |
Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
|
ATE485307T1
(de)
|
2003-11-07 |
2010-11-15 |
Ablynx Nv |
Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung
|
US8034548B2
(en)
*
|
2003-12-19 |
2011-10-11 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies
|
US20060003948A1
(en)
*
|
2004-02-06 |
2006-01-05 |
Krasutsky Pavel A |
Compositions that include a triterpene and a carrier
|
JP4934432B2
(ja)
|
2004-02-19 |
2012-05-16 |
レクサン ファーマシューティカルズ インコーポレイテッド |
キナゾリン誘導体およびキナゾリン誘導体の治療への使用
|
US20050187191A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Louis S. |
Methods and compositions for the treatment of respiratory syncytial virus
|
US20050187192A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
AU2005232526B2
(en)
*
|
2004-02-24 |
2011-06-23 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies and compounds
|
PL2574341T3
(pl)
|
2004-03-29 |
2017-09-29 |
University Of South Florida |
Efektywne leczenie guzów i raka fosforanem tricyrybiny
|
US7576069B2
(en)
*
|
2004-08-02 |
2009-08-18 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs having A2A agonist activity
|
EP2266994B1
(fr)
|
2004-08-02 |
2013-04-03 |
University Of Virginia Patent Foundation |
Analogues de 2-propynyle adenosine comprenant des groupes 5'-ribose modifies presentant une activite agoniste A2A
|
WO2006026380A2
(fr)
*
|
2004-08-25 |
2006-03-09 |
University Of Iowa Research Foundation |
Inhibiteurs de la geranylgeranyl pyrophosphate synthase
|
US7718680B2
(en)
*
|
2004-09-23 |
2010-05-18 |
Burnham Institute For Medical Research |
Inhibition of lethal factor protease activity from anthrax toxin
|
WO2006040153A2
(fr)
*
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Nanocorps™ contre la proteine beta-amyloide et polypeptides les renfermant pour le traitement de maladies degeneratives neurales, telles que la maladie d'alzheimer
|
US8697674B2
(en)
*
|
2004-12-29 |
2014-04-15 |
Naturon, Inc. |
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
|
EP1845778A2
(fr)
*
|
2005-01-10 |
2007-10-24 |
University Of Virginia Patent Foundation |
Synthese d'inhibiteurs de p90rsk
|
FR2882518B1
(fr)
*
|
2005-02-28 |
2012-10-19 |
Oreal |
Coloration de matieres keratiniques notamment humaines par transfert thermique a sec d'un colorant direct anthraquinonique, composition comprenant ledit colorant et son procede de preparation
|
US20060230546A1
(en)
*
|
2005-02-28 |
2006-10-19 |
Eric Bone |
Anhydrous composition in the form of a film comprising at least one film-forming polymer and at least one oxidation dye, preparation, and dyeing process
|
FR2882560B1
(fr)
*
|
2005-02-28 |
2007-05-18 |
Oreal |
Composition anhydre sous forme de film comprenant un polymere filmogene et un colorant d'oxydation, preparation et procede de coloration la mettant en oeuvre
|
US20060236469A1
(en)
*
|
2005-02-28 |
2006-10-26 |
Eric Bone |
Anhydrous composition in the form of a film comprising a film-forming polymer and oxidizing agent, preparation and process for coloring keratinous fibers employing the anhydrous composition
|
FR2882521B1
(fr)
*
|
2005-02-28 |
2008-05-09 |
Oreal |
Coloration de matieres keratiniques notamment humaines par transfert thermique a sec d'un colorant direct, composition comprenant ledit colorant et son procede de preparation
|
US20060242771A1
(en)
*
|
2005-02-28 |
2006-11-02 |
Eric Bone |
Anhydrous composition in the form of a film comprising a film-forming polymer and a direct dye, preparation and dyeing process using the composition
|
FR2882519B1
(fr)
*
|
2005-02-28 |
2008-12-26 |
Oreal |
Coloration de matieres keratiniques notamment humaines par transfert thermique a sec d'un colorant direct azomethinique composition comprenant ledit colorant et son procede de preparation
|
FR2882652B1
(fr)
*
|
2005-03-03 |
2007-06-08 |
Jacqueline Fellous |
Composition pharmaceutique et/ou cosmetique, procede de preparation et creme pour les mains
|
KR20070115939A
(ko)
*
|
2005-03-10 |
2007-12-06 |
제이알 켐, 엘엘씨 |
벤조일 퍼옥사이드 조성물 및 이용 방법
|
US7390431B2
(en)
*
|
2005-03-10 |
2008-06-24 |
Jr Chem, Llc |
Stable organic peroxide compositions
|
KR102481886B1
(ko)
|
2005-05-13 |
2022-12-28 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
디아릴히단토인 화합물
|
US7709517B2
(en)
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
HUE045710T2
(hu)
|
2005-05-18 |
2020-01-28 |
Ablynx Nv |
Javított, alfa tumor nekrózis faktor elleni nanobodies
|
EP3243839A1
(fr)
|
2005-05-20 |
2017-11-15 |
Ablynx N.V. |
Nano-corps améliorés pour le traitement des troubles liés à l'agrégation
|
US7556820B2
(en)
|
2005-06-29 |
2009-07-07 |
Jr Chem, Llc |
Stable organic peroxide compositions
|
US20090306023A1
(en)
*
|
2005-06-29 |
2009-12-10 |
Ramirez Jose E |
Stable organic peroxide compositions
|
US20070001145A1
(en)
*
|
2005-06-29 |
2007-01-04 |
Faryniarz Joseph R |
Stable organic peroxide compositions
|
WO2007019308A2
(fr)
*
|
2005-08-03 |
2007-02-15 |
The Regents Of The University Of California |
Analogues d'illudine utiles en tant qu'agents anticancereux
|
WO2007024707A2
(fr)
|
2005-08-22 |
2007-03-01 |
The Regents Of The University Of California |
Agonistes tlr
|
US20090291437A1
(en)
*
|
2005-11-02 |
2009-11-26 |
O'brien Sean |
Methods for targeting quadruplex sequences
|
WO2007120972A2
(fr)
*
|
2006-02-10 |
2007-10-25 |
University Of Virginia Patent Foundation |
Procede permettant de traiter l'anemie a hematies falciformes
|
WO2007098281A2
(fr)
|
2006-02-27 |
2007-08-30 |
Regents Of The University Of California |
Composés oxystérols et voie
|
WO2007111948A2
(fr)
*
|
2006-03-22 |
2007-10-04 |
The Regents Of The University Of California |
Inhibiteurs de prényltransférases protéiques
|
HUE032085T2
(en)
|
2006-03-27 |
2017-09-28 |
Univ California |
Androgen receptor modulator for the treatment of prostate cancer and androgen receptor related diseases
|
JP5350217B2
(ja)
*
|
2006-03-29 |
2013-11-27 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ジアリールチオヒダントイン化合物
|
US8093235B2
(en)
|
2006-04-25 |
2012-01-10 |
Rutgers, The State University Of New Jersey |
Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
|
US8426568B2
(en)
*
|
2006-05-22 |
2013-04-23 |
University Of Virginia Patent Foundation |
Rhamnose substituents of SL0101 and therapeutic uses thereof
|
WO2007146831A2
(fr)
*
|
2006-06-08 |
2007-12-21 |
Cylene Pharmaceuticals, Inc. |
Analogues de quinolone dérivés avec de l'acide sulfonique, du sulfonate ou du sulfonamide
|
US20110112086A1
(en)
*
|
2006-06-08 |
2011-05-12 |
Cylene Pharmaceuticals, Inc. |
Pyridinone analogs
|
US8188063B2
(en)
*
|
2006-06-19 |
2012-05-29 |
University Of Virginia Patent Foundation |
Use of adenosine A2A modulators to treat spinal cord injury
|
US8034829B2
(en)
|
2006-11-17 |
2011-10-11 |
Rexahn Pharmaceuticals, Inc. |
5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof
|
CA2670595A1
(fr)
*
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
1- [ ( 4 -chlorophenyl) amide 5-{[2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phenyl]amide) d'acide (r) -5-methyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylique servant d'inhibiteur du facteur xa
|
WO2008074839A2
(fr)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Séquences d'acides aminés dirigées contre les gpcr et polypeptides les contenant pour le traitement de maladies et de troubles liés au gpcr
|
EP2102244A2
(fr)
|
2006-12-19 |
2009-09-23 |
Ablynx N.V. |
Séquences d'acides aminés dirigées contre une métalloprotéinase de la famille adam et polypeptides les comprenant à des fins de traitement de maladies et troubles liés à adam
|
JP2010518108A
(ja)
|
2007-02-06 |
2010-05-27 |
ユニバーシティ オブ ルーイビル リサーチ ファウンデーション,インコーポレーテッド |
治療化合物
|
BRPI0807196A2
(pt)
|
2007-02-07 |
2014-06-03 |
Univ California |
Método para prevenir ou inibir uma infecção bacteriana, vacina, composto, e, método para prevenir, tratar ou inibir a asma
|
WO2008103818A1
(fr)
*
|
2007-02-21 |
2008-08-28 |
University Of Louisville Research Foundation |
Compositions thérapeutiques à base de cotinine
|
US8569449B2
(en)
|
2007-05-08 |
2013-10-29 |
University Of Louisville Research Foundation, Inc. |
Synthetic peptides and peptide mimetics
|
BRPI0815563A2
(pt)
*
|
2007-07-12 |
2015-02-18 |
Univ South Florida |
Inibidores de akt/pkb com atividade antitumoral
|
EP2185568A4
(fr)
|
2007-08-02 |
2010-08-11 |
Trustees Rutgers The State Uni |
Composés thérapeutiques
|
PT3092901T
(pt)
*
|
2007-10-05 |
2020-05-21 |
Senhwa Biosciences Inc |
Análogos de quinolona e respetivos métodos relacionados
|
EP2205088B1
(fr)
|
2007-10-19 |
2018-02-21 |
Burnham Institute for Medical Research |
Inhibiteurs à base de naphtalène de protéines anti-apoptotiques
|
WO2009055677A1
(fr)
*
|
2007-10-24 |
2009-04-30 |
University Of South Florida |
Disulfures s-hétérosubstitués antibactériens
|
TW201716385A
(zh)
|
2007-10-26 |
2017-05-16 |
加州大學董事會 |
二芳基乙內醯脲類化合物
|
EP2231164A1
(fr)
|
2007-12-03 |
2010-09-29 |
The Regents of the University of California |
Oxystérols pour l'activation du signal hedgehog, de l'ostéoinduction, de l'anti-adipogenèse et du signal wnt
|
US8058259B2
(en)
*
|
2007-12-20 |
2011-11-15 |
University Of Virginia Patent Foundation |
Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
WO2009108716A2
(fr)
|
2008-02-27 |
2009-09-03 |
University Of Louisville Research Foundation |
Peptides synthétiques
|
WO2009114539A2
(fr)
*
|
2008-03-10 |
2009-09-17 |
University Of Louisville Research Foundation |
Traitements neuroprotecteurs à base de peptide de liaison de l'intégrine et de l'angiopoïétine-1
|
US20110046101A1
(en)
*
|
2008-03-17 |
2011-02-24 |
Dmitrienko Gary I |
Bate-lactamase inhibitors
|
WO2009146112A1
(fr)
*
|
2008-04-02 |
2009-12-03 |
University Of Virginia Patent Foundation |
Compositions et procédés pour inhiber la sphingosine kinase
|
EP2947097A1
(fr)
|
2008-04-07 |
2015-11-25 |
Ablynx N.V. |
Séquences d'acides aminés dirigées contre les voies Notch et leurs utilisations
|
CA2721203C
(fr)
|
2008-04-16 |
2016-11-01 |
Howard University |
Inhibiteurs de proteine phosphatase-1 et leurs utilisations
|
US9212226B2
(en)
|
2008-05-16 |
2015-12-15 |
Ablynx N.V. |
Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same
|
US9872867B2
(en)
*
|
2008-06-06 |
2018-01-23 |
Tanya Kuritz |
Methods and compositions for modulation of innate immunity
|
WO2010005534A2
(fr)
*
|
2008-06-30 |
2010-01-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibiteurs des protéasomes pour l’induction sélective de l’apoptose dans les cellules cancéreuses
|
US7947717B2
(en)
*
|
2008-07-18 |
2011-05-24 |
Burnham Institute For Medical Research |
Inhibitors of lethal factor protease
|
WO2010011666A2
(fr)
*
|
2008-07-21 |
2010-01-28 |
University Of South Florida |
Inhibiteurs de shp-2 à squelette indoline et procédé de traitement du cancer
|
US9125821B2
(en)
|
2008-07-28 |
2015-09-08 |
The Regents Of The University Of California |
Nanodrug targeting protein geranylgeranylation
|
WO2010014054A1
(fr)
|
2008-07-28 |
2010-02-04 |
The Regents Of The University Of California |
Inhibiteurs de prényltransférases de protéine
|
US20110142795A1
(en)
|
2008-08-05 |
2011-06-16 |
University Of South Florida |
Methods of treating cognitive impairment
|
US9132168B2
(en)
|
2008-08-05 |
2015-09-15 |
University Of South Florida |
Methods of treating cognitive impairment
|
AU2009279400A1
(en)
*
|
2008-08-08 |
2010-02-11 |
University Of Florida Research Foundation, Inc. |
Lipid compounds for supression of tumorigenesis
|
TW201038578A
(en)
|
2009-01-30 |
2010-11-01 |
Univ Rutgers |
Methods to treat cancer
|
CA2755975A1
(fr)
|
2009-03-20 |
2010-09-23 |
University Of Iowa Research Foundation |
Bisphosphonates prenyles en tant qu'agents antituberculeux
|
RU2539798C2
(ru)
|
2009-04-10 |
2015-01-27 |
Аблинкс Нв |
Улучшенные аминокислотные последовательности против il-6r и содержащие их полипептиды для лечения связанных с il-6r заболеваний и нарушений
|
US8487131B2
(en)
|
2009-04-15 |
2013-07-16 |
Sanford-Burnham Medical Research Institute |
Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
|
MX2011010872A
(es)
|
2009-04-15 |
2012-01-19 |
Sanford Burnham Med Res Inst |
Inhibidores basados en naftaleno de proteinas anti-apoptoticas.
|
EP2430016B1
(fr)
|
2009-05-13 |
2020-04-01 |
University Of Virginia Patent Foundation |
Inhibiteurs de leucémie inv(16)
|
US8263762B2
(en)
|
2009-06-30 |
2012-09-11 |
Dogwood Pharmaceuticals, Inc. |
Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonists
|
WO2011005871A1
(fr)
|
2009-07-07 |
2011-01-13 |
Pgxhealth, Llc |
8-[6-carbonylamino-3-pyridyle] xanthines substituées en tant quantagonistes de ladénosine a2b
|
AU2010278730A1
(en)
|
2009-07-31 |
2012-03-01 |
Biocryst Pharmaceuticals, Inc. |
Pyrrolo [1, 2-b] pyridazine derivatives as janus kinase inhibitors
|
US9040673B2
(en)
|
2009-08-14 |
2015-05-26 |
University Of Virginia Patent Foundation |
Synthesis and identification of novel RSK-specific inhibitors
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
US8642088B2
(en)
|
2009-09-04 |
2014-02-04 |
Wisconsin Alumni Research Foundation |
Tannin-chitosan composites
|
US8937193B2
(en)
*
|
2009-10-08 |
2015-01-20 |
Sanford-Burnham Medical Research Institute |
Apogossypolone derivatives as anticancer agents
|
US8796300B2
(en)
|
2009-11-05 |
2014-08-05 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|
CN102892755A
(zh)
|
2009-12-23 |
2013-01-23 |
韦恩州立大学 |
治疗性化合物
|
WO2011079230A2
(fr)
|
2009-12-23 |
2011-06-30 |
Biocryst Pharmaceuticals, Inc. |
Composés hétérocycliques comme inhibiteurs de la janus kinase
|
EP3124481B1
(fr)
|
2010-02-16 |
2018-03-28 |
Aragon Pharmaceuticals, Inc. |
Modulateurs de récepteur d'androgène et utilisations associées
|
WO2011103686A1
(fr)
|
2010-02-26 |
2011-09-01 |
Viswanatha , Sundaramma |
Dérivés de la céphalosporine utiles comme inhibiteurs de la β-lactamase et leurs compositions et procédés d'utilisation
|
EP2552885A1
(fr)
|
2010-04-02 |
2013-02-06 |
TSRL, Inc. |
Inhibiteurs de la neuraminidase
|
US9221808B2
(en)
|
2010-04-16 |
2015-12-29 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use
|
WO2011133696A2
(fr)
|
2010-04-20 |
2011-10-27 |
Regents Of The University Of Minnesota |
Méthodes de lutte contre l'athérosclérose
|
MX2012013824A
(es)
|
2010-05-28 |
2013-03-12 |
Biocryst Pharm Inc |
Compuestos heterociclicos como inhibidores de cinasa janus.
|
WO2012027494A1
(fr)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Réactifs bispécifiques de ciblage
|
US8609672B2
(en)
|
2010-08-27 |
2013-12-17 |
University Of The Pacific |
Piperazinylpyrimidine analogues as protein kinase inhibitors
|
AU2011323784A1
(en)
|
2010-10-25 |
2013-05-30 |
Regents Of The University Of Minnesota |
Therapeutic composition for treatment of glioblastoma
|
EP3150590B1
(fr)
|
2011-02-07 |
2019-10-16 |
Biogen MA Inc. |
Agents de modulation s1p
|
EP2683837A2
(fr)
|
2011-03-07 |
2014-01-15 |
University Of Louisville Research Foundation, Inc. |
Marqueur prédictif de l'efficacité thérapeutique de l'inhibiteur dnmt1, et procédés d'utilisation dudit marqueur
|
WO2012135697A2
(fr)
|
2011-03-30 |
2012-10-04 |
H. Lee Moffitt Cancer Center & Research Institute Inc. |
Nouveaux inhibiteurs de la rho-kinase et leurs procédés d'utilisation
|
US10059746B2
(en)
|
2011-04-04 |
2018-08-28 |
University Of Iowa Research Foundation |
Methods of improving vaccine immunogenicity
|
WO2012139015A1
(fr)
|
2011-04-06 |
2012-10-11 |
Rutgers, The State University Of New Jersey |
Polymères et procédés pour le traitement de la douleur
|
US20120270860A1
(en)
|
2011-04-19 |
2012-10-25 |
Gihyun Yoon |
Methods for treating or preventing alcohol-related disorders or craving-related disorders
|
WO2012145678A1
(fr)
|
2011-04-20 |
2012-10-26 |
Regents Of The University Of Minnesota |
Composés parthénolides anticancéreux et anti-inflammatoire
|
WO2012177770A1
(fr)
|
2011-06-20 |
2012-12-27 |
Rutgers, The State University Of New Jersey |
Inhibiteurs bipartites de l'arn polymérase bactérienne
|
EP2729483A1
(fr)
|
2011-07-08 |
2014-05-14 |
Regents Of The University Of Minnesota |
Analogues du glutathion et leurs utilisations
|
WO2013016206A1
(fr)
|
2011-07-22 |
2013-01-31 |
University Of Louisville Research Foundation, Inc. |
Composés anti-biofilm
|
BR112014002200A2
(pt)
|
2011-07-29 |
2017-03-07 |
Medivation Prostate Therapeutics Inc |
tratamento de câncer de mama
|
WO2013028866A1
(fr)
|
2011-08-24 |
2013-02-28 |
Regents Of The University Of Minnesota |
Composés et méthodes thérapeutiques
|
EP2750508A4
(fr)
|
2011-08-30 |
2015-01-14 |
Univ Wayne State |
Composés et procédés thérapeutiques
|
WO2013033345A1
(fr)
|
2011-08-30 |
2013-03-07 |
Regents Of The University Of Minnesota |
Immunomodulateurs et conjugués d'immunomodulateurs
|
EP2763658B1
(fr)
|
2011-09-08 |
2021-06-23 |
Western University Of Health Sciences |
Liposomes ciblés en thérapie cancéreuse
|
US9573906B2
(en)
|
2011-09-15 |
2017-02-21 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Therapeutic compounds
|
US9828326B2
(en)
*
|
2011-12-27 |
2017-11-28 |
Northeast Ohio Medical University |
Amooranin compounds and analogs thereof and related methods of use
|
US9517994B2
(en)
|
2012-01-05 |
2016-12-13 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: phloroglucinol derivatives
|
EP2802602B1
(fr)
|
2012-01-11 |
2019-03-27 |
Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University |
Fragments des anticorps bispecifiques pour des proteines de maladies neurologiques et procedes d'utilisation
|
US8947424B2
(en)
|
2012-01-17 |
2015-02-03 |
Eastman Kodak Company |
Spectral stereoscopic projection system
|
EP2804606B1
(fr)
|
2012-01-19 |
2017-06-28 |
Hybrid Medical, LLC |
Préparations thérapeutiques topiques
|
WO2013109972A2
(fr)
|
2012-01-20 |
2013-07-25 |
Regents Of The University Of Minnesota |
Composés thérapeutiques
|
US20130195752A1
(en)
|
2012-02-01 |
2013-08-01 |
Regents Of The University Of Minnesota |
Functionalized nanoparticles and methods of use thereof
|
CA2863427C
(fr)
|
2012-02-01 |
2022-07-12 |
The Governors Of The University Of Alberta |
Utilisation de pdgfr-alpha en tant que marqueur de diagnostic pour le cancer de la thyroide papillaire
|
WO2013119564A1
(fr)
|
2012-02-06 |
2013-08-15 |
Rutgers, The State University Of New Jersey |
Agents antibactériens : combinaison d'une rifamycine et d'un inhibiteur de région de transition
|
WO2013119946A1
(fr)
|
2012-02-08 |
2013-08-15 |
Of Virginia Patent Foundation University |
Inhibiteurs de la kinase sphingosine avec base à longue chaîne
|
US9187446B2
(en)
|
2012-03-22 |
2015-11-17 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: sidechainfluorinated myxopyronin derivatives
|
ES2655027T3
(es)
|
2012-03-26 |
2018-02-16 |
University Of Iowa Research Foundation |
Análogos de schweinfurthinas
|
US9340501B2
(en)
|
2012-04-16 |
2016-05-17 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Marinopyrrole derivatives as anticancer agents
|
US9272016B2
(en)
|
2012-04-20 |
2016-03-01 |
University Of Iowa Research Foundation |
Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells
|
CN104395331B
(zh)
|
2012-05-07 |
2016-11-02 |
加利福尼亚大学董事会 |
诱导骨生成和hedgehog 信号传导且抑制脂肪形成的氧固醇类似物氧固醇化合物133
|
EP2861570B1
(fr)
|
2012-06-19 |
2018-07-18 |
Rutgers, The State University of New Jersey |
Agents antibactériens : dérivés aryliques de la myxopyronine
|
WO2013192388A1
(fr)
|
2012-06-20 |
2013-12-27 |
University Of Virginia Patent Foundation |
Compositions et procédés pour réguler l'homéostasie du glucose et l'action de l'insuline
|
US9669115B2
(en)
|
2012-06-29 |
2017-06-06 |
University Of Iowa Research Foundation |
Co-crystals and salts of contrast agents and imaging
|
ES2617448T3
(es)
|
2012-07-05 |
2017-06-19 |
University Of Iowa Research Foundation |
Bisfosfonatos terapéuticos
|
RU2696278C2
(ru)
|
2012-07-18 |
2019-08-01 |
Юниверсити Оф Нотр Дам Дю Лак |
5,5-гетероароматические противоинфекционные соединения
|
WO2014018671A1
(fr)
|
2012-07-24 |
2014-01-30 |
Regents Of The University Of Minnesota |
Composés thérapeutiques pour le traitement du cancer
|
US9522889B2
(en)
|
2012-07-27 |
2016-12-20 |
Biogen Ma Inc. |
ATX modulating agents
|
KR20150036767A
(ko)
|
2012-08-01 |
2015-04-07 |
루이스 앤드 클라크 파마슈티컬스, 인코포레이티드 |
A2a 효능제로서의 n-알킬 2-(이치환된)알키닐아데노신-5-유론아미드
|
US9249116B2
(en)
|
2012-08-03 |
2016-02-02 |
The Board Of Trustees Of The University Of Illinois |
Enzyme-activating compounds and compositions
|
WO2014025709A1
(fr)
|
2012-08-06 |
2014-02-13 |
Biogen Idec Ma Inc. |
Composés étant des agents de modulation de s1p et/ou des agents de modulation d'atx
|
WO2014025708A1
(fr)
|
2012-08-06 |
2014-02-13 |
Biogen Idec Ma Inc. |
Composés étant des agents de modulation de s1p et/ou des agents de modulation d'atx
|
WO2014031732A2
(fr)
|
2012-08-22 |
2014-02-27 |
Cornell University |
Méthodes d'inhibition de la fascine
|
WO2014039860A2
(fr)
|
2012-09-07 |
2014-03-13 |
University Of Louisville Research Foundation, Inc. |
Compositions et méthodes de modulation de l'activité inhibitrice de la dnmt1
|
US9573938B2
(en)
|
2012-09-11 |
2017-02-21 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones
|
SI3305285T1
(sl)
|
2012-09-26 |
2021-03-31 |
Aragon Pharmaceuticals, Inc. |
Anti-androgeni za zdravljenje proti kastraciji odpornega ne-metastatskega raka
|
US9957214B2
(en)
|
2012-10-10 |
2018-05-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Multifunctional radical quenchers
|
US9364406B2
(en)
|
2012-10-12 |
2016-06-14 |
Regents Of The University Of Minnesota |
Open chained or fused 1,1′-alkylene-bis-uracil derivatives, useful in skin UV-protection
|
WO2014066840A1
(fr)
|
2012-10-26 |
2014-05-01 |
Regents Of The University Of Minnesota |
Inhibiteurs d'aurora kinase
|
US10519161B2
(en)
|
2012-10-29 |
2019-12-31 |
Southern Methodist University |
Methods of generating beta-lactamase resistant carbapenem compounds
|
US9701638B2
(en)
|
2012-11-09 |
2017-07-11 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxyquinolones
|
WO2014078778A2
(fr)
|
2012-11-16 |
2014-05-22 |
Biocryst Pharmaceuticals, Inc. |
Nucléosides antiviraux contenant de l'azasucre
|
US9670199B2
(en)
|
2012-11-19 |
2017-06-06 |
Regents Of The University Of Minnesota |
Ergoline derivatives as dopamine receptor modulators
|
US9850206B2
(en)
|
2012-11-20 |
2017-12-26 |
Biogen Ma Inc. |
S1P and/or ATX modulating agents
|
WO2014081756A1
(fr)
|
2012-11-20 |
2014-05-30 |
Biogen Idec Ma Inc. |
Agents de modulation de s1p et/ou atx
|
JOP20200097A1
(ar)
|
2013-01-15 |
2017-06-16 |
Aragon Pharmaceuticals Inc |
معدل مستقبل أندروجين واستخداماته
|
US9700044B2
(en)
|
2013-01-22 |
2017-07-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Symmetrical marinopyrrole derivatives as potential antibiotic agents
|
US9765016B2
(en)
|
2013-01-29 |
2017-09-19 |
Biogen Ma Inc. |
S1P modulating agents
|
WO2014124317A1
(fr)
|
2013-02-08 |
2014-08-14 |
Regents Of The University Of Minnesota |
Conjugués analgésiques
|
JP2016510749A
(ja)
|
2013-03-05 |
2016-04-11 |
ユニヴァーシティー オブ ノートル ダム デュ ラック |
キナゾリノン抗生物質
|
WO2014158685A2
(fr)
*
|
2013-03-14 |
2014-10-02 |
Avon Products, Inc |
Extraits de tetracera asiatica et procédés d'utilisation
|
US9387250B2
(en)
|
2013-03-15 |
2016-07-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions for bone repair
|
EP2968263A2
(fr)
|
2013-03-15 |
2016-01-20 |
Genentech, Inc. |
Traitement de maladies th2 par inhibition des protéines brd7 et brd9 contenant un bromodomaine
|
WO2014143672A1
(fr)
|
2013-03-15 |
2014-09-18 |
Biogen Idec Ma Inc. |
Composés macrocycliques en tant qu'inhibiteurs de irak4 pour le traitement de maladies inflammatoires
|
US20160039825A1
(en)
|
2013-03-15 |
2016-02-11 |
Biogen Ma Inc. |
S1p and/or atx modulating agents
|
WO2014179756A1
(fr)
|
2013-05-02 |
2014-11-06 |
The Regents Of The University Of California |
Agents de ciblage osseux à base d'oxystérol ostéogène à sélectivité osseuse
|
US9862672B2
(en)
|
2013-05-29 |
2018-01-09 |
Rutgers, The State University Of New Jersey |
Antioxidant-based poly(anhydride-esters)
|
WO2015003095A1
(fr)
|
2013-07-03 |
2015-01-08 |
Regents Of The University Of Minnesota |
Composés et compositions de bronzage sans soleil
|
WO2015021149A1
(fr)
|
2013-08-06 |
2015-02-12 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibiteurs de la tyrosine kinase ack1/tnk2
|
CN106102758B
(zh)
|
2013-11-11 |
2020-09-22 |
夸利蒂赫布丘蒂克斯公司 |
卡瓦衍生的治疗性化合物及其使用方法
|
US9339482B2
(en)
|
2013-11-22 |
2016-05-17 |
Regents Of The University Of Minnesota |
Methods to treat dysregulated blood glucose disorders
|
US9315523B2
(en)
|
2013-12-06 |
2016-04-19 |
Rutgers, The State University Of New Jersey |
Cyclic dinucleosides
|
EP3102193B1
(fr)
|
2014-02-06 |
2023-01-11 |
Rutgers, The State University of New Jersey |
Agents antibactériens : n(alpha)-aroyl-n-aryl-phénylalaninamides
|
WO2015127125A1
(fr)
|
2014-02-20 |
2015-08-27 |
Cornell University |
Composés et procédés d'inhibition de la fascine
|
WO2015130805A1
(fr)
|
2014-02-26 |
2015-09-03 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Compositions de grille d'adn et procédés
|
US10272055B2
(en)
|
2014-03-06 |
2019-04-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
RS61159B1
(sr)
|
2014-03-07 |
2021-01-29 |
Biocryst Pharm Inc |
Pirazoli supstituisani trifluorometilom kao inhibitori humanog kalikreina plazme
|
US10197575B2
(en)
|
2014-03-31 |
2019-02-05 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Stabilized peptoid-peptide hybrids and uses thereof
|
CA2946112C
(fr)
|
2014-04-18 |
2020-11-24 |
The Governors Of The University Of Alberta |
Therapie ciblee pour restaurer le transport de l'iode radioactif pour traiter le cancer de la thyroide
|
US9556113B2
(en)
|
2014-04-29 |
2017-01-31 |
The South Dakota Board Of Regents |
Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment
|
CA2945404A1
(fr)
|
2014-05-02 |
2015-11-05 |
The Regents Of The University Of California |
Analogues de bisphosphonates d'oxysterol osteogeniques ciblant specifiquement l'os
|
US9987299B2
(en)
|
2014-05-05 |
2018-06-05 |
University Of Iowa Research Foundation |
Methods of improving RNAi in well-differentiated airway epithelia
|
TW201613917A
(en)
|
2014-06-06 |
2016-04-16 |
Biogen Ma Inc |
ATX modulating agents
|
US10138203B2
(en)
|
2014-06-16 |
2018-11-27 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
US9737598B2
(en)
|
2014-06-30 |
2017-08-22 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
AU2015304860B2
(en)
|
2014-08-19 |
2020-07-16 |
Hsiri Therapeutics, LLC |
Antibacterial sideromycins
|
US11135178B2
(en)
|
2014-09-11 |
2021-10-05 |
University Of Iowa Research Foundation |
Thymol and carvacol for use in medicine
|
WO2016076929A1
(fr)
|
2014-11-13 |
2016-05-19 |
University Of Iowa Research Foundation |
Procédés pour générer des cellules épithéliales
|
DK3258938T3
(da)
|
2015-02-17 |
2021-02-01 |
Univ Arizona State |
Phenothiazinanaloger som mitokondrie terapeutiske midler
|
US10364227B2
(en)
|
2015-02-17 |
2019-07-30 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
WO2016172187A1
(fr)
|
2015-04-20 |
2016-10-27 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Méthodes et compositions associées à des inhibiteurs de kras
|
JP6959142B2
(ja)
|
2015-05-06 |
2021-11-02 |
エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド |
Mc1rを標的とする放射線療法用作用物質およびコンパニオンイメージング作用物質
|
CN108026084A
(zh)
|
2015-05-07 |
2018-05-11 |
夸利蒂赫布丘蒂克斯公司 |
治疗化合物及其使用方法
|
CA2986423C
(fr)
|
2015-05-18 |
2022-05-10 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Amelioration de la prevention du cancer par de nouvelles melanotrines
|
US11369569B2
(en)
|
2015-06-15 |
2022-06-28 |
University Of Virginia Patent Foundation |
Target-specific delivery of therapeutic agents
|
US10308663B2
(en)
|
2015-06-16 |
2019-06-04 |
University Of Virginia Patent Foundation |
Inhibitors of PTP4A3 for the treatment of cancer
|
WO2017011686A1
(fr)
|
2015-07-14 |
2017-01-19 |
University Of Iowa Research Foundation |
Promédicaments fluorescents
|
EP3328372A4
(fr)
|
2015-07-28 |
2019-03-20 |
University Of Iowa Research Foundation |
Compositions et méthodes de traitement du cancer
|
EP3328496A4
(fr)
|
2015-08-02 |
2018-12-19 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibiteurs de la tyrosine kinase ack1/tnk2
|
US10550124B2
(en)
|
2015-08-13 |
2020-02-04 |
San Diego State University Foundation |
Atropisomerism for increased kinase inhibitor selectivity
|
JP6639651B2
(ja)
|
2015-09-04 |
2020-02-05 |
ヤンセン ファーマシューティカ エヌ.ベー. |
疼痛のための治療化合物及びその合成
|
FI4019022T3
(fi)
|
2015-10-01 |
2024-04-19 |
Biocryst Pharm Inc |
Ihmisen plasman kallikreiinin estäjiä
|
EP3355938B1
(fr)
|
2015-10-01 |
2024-02-07 |
Goleini Inc. |
Expression ciblée de canaux chlorure et procédés d'utilisation de celle-ci
|
US10738016B2
(en)
|
2015-10-13 |
2020-08-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
BRD4-kinase inhibitors as cancer therapeutics
|
EP3370763B1
(fr)
|
2015-11-03 |
2024-04-10 |
Regents of the University of Minnesota |
Inhibiteurs de cd200 et leurs méthodes d'utilisation
|
KR20180113976A
(ko)
|
2015-11-20 |
2018-10-17 |
센화 바이오사이언시즈 인코포레이티드 |
암을 치료하기 위한 테트라사이클릭 퀴놀론 유사체의 병행 요법
|
US9957282B2
(en)
|
2015-12-14 |
2018-05-01 |
Senhwa Biosciences, Inc. |
Crystalline forms of quinolone analogs and their salts
|
US9980951B2
(en)
|
2015-12-17 |
2018-05-29 |
University Of Iowa Research Foundation |
Image guided therapy for cancer
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
TWI747873B
(zh)
|
2016-02-01 |
2021-12-01 |
美商百歐克斯製藥公司 |
苯并吡唑化合物及其類似物
|
WO2017156527A1
(fr)
|
2016-03-11 |
2017-09-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibiteurs des kinases aurora et des janus kinases pour la prévention de la maladie du greffon contre l'hôte
|
US11395820B2
(en)
|
2016-03-16 |
2022-07-26 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Small molecules against cereblon to enhance effector t cell function
|
US11529340B2
(en)
|
2016-03-22 |
2022-12-20 |
Regents Of The University Of Minnesota |
Combination for treating pain
|
US10759740B2
(en)
|
2016-03-24 |
2020-09-01 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
CA3019945A1
(fr)
|
2016-04-04 |
2017-10-12 |
Rutgers, The State University Of New Jersey |
Poisons de topoisomerase
|
US10551384B2
(en)
|
2016-04-07 |
2020-02-04 |
Rutgers, The State University Of New Jersey |
MTOR kinase mutations and methods of use thereof
|
US20200237840A1
(en)
|
2016-04-18 |
2020-07-30 |
Kenneth Michael MORROW |
Isolation of plant extracts
|
EP3452110A4
(fr)
|
2016-05-04 |
2019-12-25 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Agent ciblé sur un récepteur opioïde de type delta pour l'imagerie moléculaire et l'immunothérapie du cancer
|
US10899793B2
(en)
|
2016-05-27 |
2021-01-26 |
Regents Of The University Of Minnesota |
Melanocortin ligands and methods of use thereof
|
JP2019526617A
(ja)
|
2016-06-20 |
2019-09-19 |
ラトガース ザ ステイト ユニバーシティー オブ ニュージャージー |
治療用化合物
|
AU2017281940B2
(en)
|
2016-06-24 |
2024-07-11 |
University Of Iowa Research Foundation |
Compositions and methods of treating melanoma
|
EP3490552B1
(fr)
|
2016-07-26 |
2022-11-23 |
University of Southern California |
Inhibition sélective de bromodomaine de bdf1 fongique
|
WO2018039077A1
(fr)
|
2016-08-25 |
2018-03-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Composés thérapeutiques
|
EP3526205A4
(fr)
|
2016-10-17 |
2020-05-27 |
Genentech, Inc. |
Composés thérapeutiques et leurs procédés d'utilisation
|
US11124541B2
(en)
|
2016-10-18 |
2021-09-21 |
Regents Of The University Of Minnesota |
Chimeric melanocortin ligands and methods of use thereof
|
EP3532057B1
(fr)
|
2016-10-31 |
2022-12-21 |
Biocryst Pharmaceuticals, Inc. |
Promédicaments d'inhibiteurs de la kallicréine
|
AU2017367092B2
(en)
|
2016-11-29 |
2022-11-03 |
University Of Iowa Research Foundation |
Use of NAD precursors for improving maternal health and/or offspring health
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
US10710957B2
(en)
|
2017-01-09 |
2020-07-14 |
University Of Central Florida Research Foundation, Inc. |
Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
|
CN110325508B
(zh)
|
2017-01-20 |
2023-06-30 |
加利福尼亚大学董事会 |
雄激素受体的n-末端结构域的抑制剂
|
US10231947B2
(en)
|
2017-01-23 |
2019-03-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Isochroman compounds and methods of use thereof
|
US10238626B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
US10238655B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dihydroindene and tetrahydronaphthalene compounds
|
US11090289B2
(en)
|
2017-01-24 |
2021-08-17 |
University Of Virginia Patent Foundation |
Compositions and methods for blocking sodium channels
|
US10294264B2
(en)
|
2017-04-21 |
2019-05-21 |
Warsaw Orthopedic, Inc. |
Oxysterol-therapeutic agent derivative for bone healing
|
CA3063174A1
(fr)
|
2017-05-12 |
2018-11-15 |
Innovus Pharmaceuticals, Inc. |
Methodes therapeutiques et compositions associees
|
US10434106B2
(en)
|
2017-05-19 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Oxysterol-statin compounds for bone growth
|
US11896591B2
(en)
|
2017-05-22 |
2024-02-13 |
University Of Virginia Patent Foundation |
Compositions and methods for preparing and using mitochondrial uncouplers
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
ES2968421T3
(es)
|
2017-06-23 |
2024-05-09 |
San Diego State Univ Research Foundation |
Atropisomerismo para la selectividad potenciada de inhibidor de cinasa
|
WO2019046467A1
(fr)
|
2017-08-29 |
2019-03-07 |
Rutgers, The State University Of New Jersey |
Indazoles thérapeutiques
|
US11254941B2
(en)
|
2017-08-30 |
2022-02-22 |
Arizona Board Of Regents On Behalf Of Arizona State University |
RNA nanostructures and methods of making and using RNA nanostructures
|
JP2020536891A
(ja)
|
2017-10-06 |
2020-12-17 |
ブルー セラピューティクス,インコーポレイティド |
急性又は慢性疼痛を治療する方法
|
JOP20200076A1
(ar)
|
2017-10-16 |
2020-04-30 |
Aragon Pharmaceuticals Inc |
مضادات أندروجين لعلاج سرطان البروستاتا غير النقيلي المقاوم للاستئصال
|
US12037416B2
(en)
|
2017-11-17 |
2024-07-16 |
Cytogel Pharma, Llc |
Polymer agonists of mu opioid receptors
|
CA3082575A1
(fr)
|
2017-11-17 |
2019-05-23 |
The Board Of Trustees Of The University Of Illinois |
Traitement du cancer par degradation de la signalisation double de mek
|
ES2969958T3
(es)
|
2017-11-30 |
2024-05-23 |
Cytogel Pharma Llc |
Formulaciones farmacéuticas analgésicas novedosas y usos de las mismas
|
US11242533B2
(en)
|
2018-01-10 |
2022-02-08 |
Arizona Board Of Regents On Behalf Of Arizona State University |
RNA-nanostructured double robots and methods of use thereof
|
US10738093B2
(en)
|
2018-01-25 |
2020-08-11 |
The Hong Kong University Of Science And Technology |
Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining
|
WO2019160873A1
(fr)
|
2018-02-13 |
2019-08-22 |
Rutgers, The State University Of New Jersey |
Agents antibactériens : pyronines o-alkyl-deutérés
|
US20190374550A1
(en)
|
2018-02-15 |
2019-12-12 |
Senhwa Biosciences, Inc. |
Quinolone analogs and their salts, compositions, and method for their use
|
WO2019168921A1
(fr)
|
2018-02-27 |
2019-09-06 |
University Of Virginia Patent Foundation |
Inhibiteur de liposomes/parp ciblés par plectine dans le traitement du cancer
|
US11572337B2
(en)
|
2018-03-06 |
2023-02-07 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: arylalkylcarboxamido phloroglucinols
|
TW202010742A
(zh)
|
2018-04-06 |
2020-03-16 |
美商百歐克斯製藥公司 |
取代的苯并呋喃、苯并吡咯、苯并噻吩及結構相關的補體抑制劑
|
US20210253538A1
(en)
|
2018-04-20 |
2021-08-19 |
Virginia Tech Intellectual Properties, Inc. |
Aminopyrazines and related compounds useful as mitochondrial uncouplers
|
WO2020036654A2
(fr)
|
2018-04-27 |
2020-02-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Topologies moléculaires hautement nouées à partir d'acides nucléiques monocaténaires
|
US10758594B2
(en)
|
2018-06-26 |
2020-09-01 |
Marine Essence Biosciences Corporation of USA |
Biomaterial devices and topical compositions for treatment of skin abnormalities
|
US10912822B2
(en)
|
2018-06-26 |
2021-02-09 |
Marine Essence Biosciences Corporation of USA |
Biomaterial devices and topical compositions for guided tissue regeneration
|
PE20210184A1
(es)
|
2018-07-11 |
2021-02-02 |
H Lee Moffitt Cancer Ct & Res |
Compuestos inmunomoduladores dimericos contra mecanismos basados en cereblon
|
US10898460B1
(en)
|
2018-07-20 |
2021-01-26 |
University Of South Florida |
Leishmania inhibitors
|
US11987568B2
(en)
|
2018-08-03 |
2024-05-21 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Allosteric inhibitor of WEE1 kinase
|
US11332499B2
(en)
|
2018-08-16 |
2022-05-17 |
Regents Of The University Of Minnesota |
Cyclic peptides and methods of use thereof
|
WO2020106454A2
(fr)
|
2018-11-07 |
2020-05-28 |
Regents Of The University Of Minnesota |
Compositions analgésiques et anti-accoutumance pour le traitement de la douleur chronique et de la dépendance aux opioïdes
|
EP3887401A2
(fr)
|
2018-11-26 |
2021-10-06 |
Denali Therapeutics Inc. |
Procédés de traitement du métabolisme lipidique dérégulé
|
AU2020208192A1
(en)
|
2019-01-14 |
2021-08-05 |
Regents Of The University Of Minnesota |
CD200AR ligands for cancer immunotherapy
|
US10889601B2
(en)
|
2019-02-11 |
2021-01-12 |
University Of Iowa Research Foundation |
Separations using boron containing hydrocarbon sponges
|
WO2020225779A1
(fr)
|
2019-05-09 |
2020-11-12 |
Istituto Pasteur Italia - Fondazione Cenci Bolognetti |
Agonistes de rig-i pour le traitement du cancer et l'immunothérapie
|
WO2020263989A1
(fr)
|
2019-06-24 |
2020-12-30 |
University Of Iowa Research Foundation |
Inhibiteurs de jnk en tant qu'agents anticancéreux
|
US11840703B2
(en)
|
2019-07-01 |
2023-12-12 |
Matrexa LLC |
Recombinant versican isoforms and related compositions and methods
|
KR20220044276A
(ko)
|
2019-08-06 |
2022-04-07 |
바이오크리스트파마슈티컬즈,인코포레이티드 |
혈장 칼리크레인 억제제의 공정-스케일 합성
|
US20230146256A1
(en)
|
2020-04-17 |
2023-05-11 |
Regents Of The University Of Minnesota |
SARS-CoV-2 SPIKE RECEPTOR BINDING DOMAIN AND COMPOSITIONS AND METHODS THEREOF
|
US11529335B2
(en)
|
2020-07-31 |
2022-12-20 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
WO2022155332A1
(fr)
|
2021-01-13 |
2022-07-21 |
Blue Therapeutics, Inc. |
Méthodes de traitement du syndrome du côlon irritable
|
MX2023009729A
(es)
|
2021-02-22 |
2023-09-25 |
Univ Minnesota |
Inmunomoduladores y conjugados de inmunomoduladores.
|
US11780828B2
(en)
|
2021-05-04 |
2023-10-10 |
Regents Of The University Of Minnesota |
Contraceptive compounds and methods
|
WO2023081237A1
(fr)
|
2021-11-03 |
2023-05-11 |
Regents Of The University Of Minnesota |
Agonistes et antagonistes du récepteur de type toll et leurs utilisations
|
WO2023091689A1
(fr)
|
2021-11-19 |
2023-05-25 |
University Of Iowa Research Foundation |
Utilisation associée de radiothérapie dirigée par mcr1 et d'inhibition du point de contrôle immunitaire dans le traitement d'un mélanome
|
WO2024006977A1
(fr)
|
2022-07-01 |
2024-01-04 |
University Of Southern California |
Ligands bitopiques du récepteur opioïde delta analgésique
|
WO2024009283A1
(fr)
|
2022-07-07 |
2024-01-11 |
University Of Southern California |
Antagonistes at2 pour soulager la douleur non addictive
|
TW202409024A
(zh)
|
2022-07-08 |
2024-03-01 |
美商愛克堤歐生物科學公司 |
治療性化合物及方法
|
WO2024102342A1
(fr)
|
2022-11-10 |
2024-05-16 |
University Of Iowa Research Foundation |
Combinaison d'un inhibiteur de la synthèse du glutathion tel que la buthionine sulfoximine et d'un inhibiteur de point de contrôle immunitaire, de préférence le pembrolizumab, pour traiter le cancer, de préférence un mélanome résistant aux médicaments
|
WO2024112932A1
(fr)
|
2022-11-23 |
2024-05-30 |
Regents Of The University Of Minnesota |
Immunomodulateurs et conjugués immunomodulateurs
|
WO2024124023A2
(fr)
|
2022-12-07 |
2024-06-13 |
Rutgers, The State University Of New Jersey |
Inhibiteurs d'enzyme anhydrase carbonique et leurs procédés d'utilisation
|